Review of 2013-2014 Mobile Medical Applications: Regulatory Challenges and Precedents
Keywords:
mobile medical applications, mobile medical devices, biodesign, regulation, FDA, global, mHealth, mobile health, entrepreneurshipAbstract
This project aims to offer a review of mobile medical apps and the most important changes that happened in this sector in 2013 and 2014. We start with a discussion about the regulation of these devices in the United States, the European Union, and Brazil. 2013 was a significant year because of the publication of important guidelines about regulation and classification of mobile apps as medical devices. We further discuss how the manufacturers look at the requirements of safety and efficiency and how they are assessing these outcomes. Next, we explore the value proposition of mobile medical applications. Finally, we explore three case studies of mobile medical applications; one intended for imaging diagnostics, called ResolutionMDTM, by Calgary Scientific Inc., another, MyVisonTrackTM, by Virtual Art and Science, Inc., and a third, unregulated application from GN ReSound called ReSound SmartTM. The information for this project was mainly gathered using secondary research. For this purpose, we used databases, medical, business and mobile health reports, medical journals, and medical and mobile health websites. The time frame for data was mainly between 2010 and 2014, with only one reference each from 2002, 2004, and 2008. As the world becomes increasingly more mobile and moves to a value-based healthcare system, mobile medical applications offer a huge opportunity to provide cost-effectiveness, patient empowerment and good health outcomes. 2013 and 2014 were significant years for the first steps of the regulatory agencies towards more structured guidance on this matter, but health application developers seemingly have yet to fully understand the importance of providing safer and more efficient apps to patients and providers.Downloads
Published
2014-11-28
Issue
Section
Research Articles
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).